Natural killer cell proliferation induced by anti-NK1.1 and IL-2

被引:23
作者
Reichlin, A
Yokoyama, WM
机构
[1] Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol,Dept Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Div Newborn Med, Dept Pediat, St Louis, MO 63110 USA
[3] Mt Sinai Med Ctr, Dept Pediat, New York, NY 10029 USA
关键词
cellular activation; cellular proliferation; cytotoxicity; NK1.1; NK cells; NKR-P1;
D O I
10.1046/j.1440-1711.1998.00726.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
NKR-P1 molecules are involved in natural killing of certain tumour targets. Indeed, the NK1.1 (NKR-P1C) molecule is the most specific serological marker on murine NK cells in C57BL/6 mice. Previous studies of NKR-P1 have indicated that anti-NKR-P1 mAb induced NK cells to kill otherwise insensitive targets, NK cell phosphoinositol turnover and Ca++ flux but it was not previously known if all NK cells were activated. In this study we report that immobilized anti-NK1.1 also specifically induced proliferation as measured by thymidine incorporation. The response required low doses of IL-2 for a synergistic effect. Cells stimulated with anti-NK1.1 + IL-2 displayed characteristic cytolytic activity against a NK-sensitive tumour target, YAC-1. However, anti-NK1.1-stimulated cells displayed delayed proliferation kinetics, heterogeneity of the expression of the very early antigen marker, CD69, and altered expression of the Ly-49 family members when compared to NK cells activated by high concentrations of IL-2. Taken together, these data demonstrate that immobilized anti-NK1.1 triggers only a subpopulation of NK cells.
引用
收藏
页码:143 / 152
页数:10
相关论文
共 46 条
[31]  
PATEL MR, 1984, IMMUNOLOGY, V53, P721
[32]   DISSECTION OF THE LYMPHOKINE-ACTIVATED KILLER PHENOMENON - RELATIVE CONTRIBUTION OF PERIPHERAL-BLOOD NATURAL-KILLER-CELLS AND LYMPHOCYTES-T TO CYTOLYSIS [J].
PHILLIPS, JH ;
LANIER, LL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (03) :814-825
[33]   NKR-P1A IS A TARGET-SPECIFIC RECEPTOR THAT ACTIVATES NATURAL-KILLER-CELL CYTOTOXICITY [J].
RYAN, JC ;
NIEMI, EC ;
NAKAMURA, MC ;
SEAMAN, WE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1911-1915
[34]  
RYAN JC, 1992, J IMMUNOL, V149, P1631
[35]  
RYAN JC, 1991, J IMMUNOL, V147, P3244
[36]  
SEAMAN WE, 1987, J IMMUNOL, V138, P4539
[37]  
SENTMAN CL, 1989, J IMMUNOL, V142, P1847
[38]   CLONING AND CHARACTERIZATION OF 5E6(LY-49C), A RECEPTOR MOLECULE EXPRESSED ON A SUBSET OF MURINE NATURAL-KILLER-CELLS [J].
STONEMAN, ER ;
BENNETT, M ;
AN, JB ;
CHESNUT, KA ;
WAKELAND, EK ;
SCHEERER, JB ;
SICILIANO, MJ ;
KUMAR, V ;
MATHEW, PA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (02) :305-313
[39]   IL-15: A pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels [J].
Tagaya, Y ;
Bamford, RN ;
DeFilippis, AP ;
Waldmann, TA .
IMMUNITY, 1996, 4 (04) :329-336
[40]   CHARACTERISTICS OF HUMAN LARGE GRANULAR LYMPHOCYTES AND RELATIONSHIP TO NATURAL-KILLER AND K-CELLS [J].
TIMONEN, T ;
ORTALDO, JR ;
HERBERMAN, RB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 153 (03) :569-582